​
​

Athira Pharma Ownership | Who Owns Athira Pharma?

OverviewForecastRevenueFinancialsChart

Athira Pharma Ownership Summary

Athira Pharma is owned by 57.91% institutional investors, 1.95% insiders, and 40.14% retail investors. Perceptive advisors is the largest institutional shareholder, holding 14.10% of ATHA shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.86% of its assets in Athira Pharma shares.

ATHA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAthira Pharma57.91%1.95%40.14%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors5.40M14.10%$14.32M
Vanguard group1.63M4.26%$4.33M
Simplify asset management1.49M3.90%$3.96M
Propel bio management1.49M3.90%$3.96M
Tang capital management1.05M2.75%$2.79M
Blackrock676.24K1.76%$1.79M
Dimensional fund advisors lp550.35K1.44%$1.46M
Jacobs levy equity management506.81K1.32%$1.34M
Pathstone492.23K1.28%$1.30M
Two sigma advisers, lp360.90K0.94%$956.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management1.49M2.57%$3.96M
Perceptive advisors5.40M0.34%$14.32M
Tang capital management1.05M0.28%$2.79M
Simplify asset management1.49M0.27%$3.96M
Laird norton trust company147.31K0.06%$390.37K
Integrity financial corp /wa32.79K0.05%$86.88K
Bristlecone advisors85.31K0.02%$226.06K
Occudo quantitative strategies lp40.48K0.02%$107.27K
Sargent investment group19.52K0.01%$51.72K
Clarius group53.55K0.01%$141.91K

Top Buyers

HolderShares% AssetsChange
Tang capital management1.05M0.28%200.00K
Dimensional fund advisors lp550.35K0.00%111.76K
Royal bank of canada55.41K-47.36K
Invst27.00K0.01%27.00K
Jacobs levy equity management506.81K0.01%9.34K

Top Sellers

HolderShares% AssetsChange
Baker bros. advisors lp---3.15M
Wasatch advisors lp---1.30M
Bml capital management---900.00K
Acadian asset management318.09K0.00%-231.85K
Nan fung group---180.00K

New Positions

HolderShares% AssetsChangeValue
Invst27.00K0.01%27.00K$67.77K

Sold Out

HolderChange
Householder group estate & retirement specialist-150.00
Mather group, llc.-175.00
Wells fargo & company/mn-238.00
Macquarie group-520.00
Tower research capital llc (trc)-4.56K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202469-12.66%22,193,5502.25%571.79%15-58.33%2327.78%
Mar 31, 20247917.91%21,705,121-0.90%561.72%3663.64%18-10.00%
Dec 31, 202367-8.22%21,901,5532.19%571.81%2222.22%20-33.33%
Sep 30, 202373-8.75%21,432,485-2.08%561.69%18-40.00%30-11.76%
Jun 30, 202380-5.88%21,887,594-8.04%571.47%30-18.92%3417.24%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Simplify Propel Opportunities ETF1.49M3.86%-
Vanguard Total Stock Mkt Idx Inv1.12M2.90%-
Wasatch Micro Cap646.90K1.68%646.90K
Wasatch Ultra Growth544.27K1.42%544.27K
Vanguard Institutional Extnd Mkt Idx Tr452.02K1.18%-
Fidelity Extended Market Index176.20K0.46%-3.20K
DFA US Targeted Value I167.67K0.44%-
Bridgeway Ultra-Small Company Market129.18K0.34%-
DFA US Small Cap I88.44K0.23%3.34K
iShares Micro-Cap ETF74.53K0.19%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 05, 2024Gengos Andrew CFO and Chief Business OfficerSell$719.95
Sep 05, 2024Lenington Rachel COO and CDOSell$1.43K
Sep 05, 2024CHURCH KEVIN CHIEF SCIENTIFIC OFFICERSell$1.43K
Sep 05, 2024Worthington Mark GENERAL COUNSELSell$1.43K
Sep 05, 2024Litton Mark James President and CEOSell$2.85K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3-5
2024 Q22-
2024 Q1-5
2023 Q43-

ATHA Ownership FAQ

Who Owns Athira Pharma?

Athira Pharma shareholders are primarily institutional investors at 57.91%, followed by 1.95% insiders and 40.14% retail investors. The average institutional ownership in Athira Pharma's industry, Biotech Stocks , is 44.97%, which Athira Pharma exceeds.

Who owns the most shares of Athira Pharma?

Athira Pharma’s largest shareholders are Perceptive advisors (5.4M shares, 14.10%), Vanguard group (1.63M shares, 4.26%), and Simplify asset management (1.49M shares, 3.90%). Together, they hold 22.26% of Athira Pharma’s total shares outstanding.

Does Blackrock own Athira Pharma?

Yes, BlackRock owns 1.76% of Athira Pharma, totaling 676.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.79M$. In the last quarter, BlackRock increased its holdings by 8.97K shares, a 1.34% change.

Who is Athira Pharma’s biggest shareholder by percentage of total assets invested?

Propel bio management is Athira Pharma’s biggest shareholder by percentage of total assets invested, with 2.57% of its assets in 1.49M Athira Pharma shares, valued at 3.96M$.

Who is the top mutual fund holder of Athira Pharma shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Athira Pharma shares, with 3.86% of its total shares outstanding invested in 1.49M Athira Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools